DR. JOHN YIANNI, CEO
PhD in Biophysics, Founder, CEO, Board member of several medical device companies (Biocompatibles, Thermocore, Reverse Medical); launched first coated coronary stent in EU (exit to Abbott); Founder and Board member Reverse medical (exit to Medtronic), Partner, Earlybird Venture Capital Health Fund.
SEBASTIEN COLLART, CFO
MSc in Political Science & Business engineering, 15 years experience in finance within SMEs in start-up, scale-up or restructuring phases. Before joining Cryotherapeutics in 2021, spent some years in a start-up active in the Medtech industry at Kiomed Pharma.
DR. PIERRE DOUETTE, REGULATORY & STRATEGIC CONSULTANT
PhD Biochemistry & Masters in Management, 15 years in regulatory & clinical, quality & operations in medtech. Prior to joining led approval of two innovative Class III devices in orthopedics & dermatology at KiOmed Pharma. Previously manager in quality operations at Artialis, Eurogentec and GSK.
URSULA MORJARIA, VP CLINICAL AFFAIRS
BSc in Medical Biology and MBA, a seasoned clinical executive combining 20 years of experience in Medtech and Pharma, across startups (Metronom Health, Celyad/Cardio3 Biosciences) and large corporations (Medtronic, GE Healthcare).